Apotex pays Bristol, Sanofi damages over Plavix - The San Diego.
Feb 8, 2012. Apotex pays Bristol, Sanofi damages over Plavix. FILE - This July 28, 2006 file photo, shows the blood thinner medication Plavix, in New York. face "patent cliffs," periods where new generic rivals will quickly eat into sales. Aug 27, 2012. Plavix rivals have been using a variety of messaging strategies that either. and the earlier news that an experimental schizophrenia drug had. Feb 1, 2014. greater efficacy than the market leader Plavix, the world's second best selling product. Pre-positioning of Effient by its rival BMS underscores how. forcing launch companies to position their new agents months or years. the drug's unique selling proposition, typically including the brand name, product.
Genetic Tests Get Mixed Results For Blood Thinners Shots - Health.
Aug 30, 2010. In anticipation of a generic version of the blood thinner Plavix. The findings were published online by the New England Journal of Medicine. to see if Plavix is just as good as Effient, a rival brand-name drug that's now. Jul 25, 2011. Generic competition will decimate sales of the brand-name drugs and. alone is taken by about 4.3 million Americans and Plavix by 1.4 million. drugs that have new generic rivals, and U. S. drug and biotech companies are.